16-66995700-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_StrongBP6_Moderate
The NM_001364782.1(CES4A):c.131G>A(p.Gly44Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000348 in 1,614,212 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001364782.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CES4A | NM_001364782.1 | c.131G>A | p.Gly44Glu | missense_variant | 2/14 | ENST00000648724.3 | NP_001351711.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CES4A | ENST00000648724.3 | c.131G>A | p.Gly44Glu | missense_variant | 2/14 | NM_001364782.1 | ENSP00000497868 | P1 | ||
CES4A | ENST00000538199.5 | c.20G>A | p.Gly7Glu | missense_variant | 1/11 | 1 | ENSP00000441103 | |||
CES4A | ENST00000540947.6 | c.131G>A | p.Gly44Glu | missense_variant | 2/12 | 2 | ENSP00000444052 | |||
CES4A | ENST00000567587.6 | c.74G>A | p.Gly25Glu | missense_variant, NMD_transcript_variant | 1/11 | 5 | ENSP00000458664 |
Frequencies
GnomAD3 genomes AF: 0.000302 AC: 46AN: 152210Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000497 AC: 124AN: 249576Hom.: 0 AF XY: 0.000384 AC XY: 52AN XY: 135402
GnomAD4 exome AF: 0.000353 AC: 516AN: 1461884Hom.: 1 Cov.: 31 AF XY: 0.000353 AC XY: 257AN XY: 727244
GnomAD4 genome AF: 0.000302 AC: 46AN: 152328Hom.: 1 Cov.: 32 AF XY: 0.000336 AC XY: 25AN XY: 74494
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 15, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at